Glocalization

UpHealth Announces Second Quarter 2023 Financial Results

Retrieved on: 
Thursday, August 10, 2023
UPH, Note, Employment, International, Table, Integrated care, RSU, Telephone, Asia Innovations Group, Sale, IGI, EBITDA, Behavior, Acquisition, NYSE Listed Company Manual, Webcast, Growth, NYSE, Bank, Video game, Film industry, Cryptocurrency, Risk management, Bookkeeping, Fine chemical, Glocalization, Marketing, Adjustment

Improved 9% to $27.2 million

Key Points: 
  • Improved 9% to $27.2 million
    Closed Strategic Sale of Innovations Group, Inc. for $56.0 million
    DELRAY BEACH, Fla., Aug. 10, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. (“UpHealth” or the “Company”) (NYSE: UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced financial results for the second quarter ended June 30, 2023.
  • Given the second quarter results and execution, we are in a position to increase our full year 2023 outlook.
  • There were no revenues in the second quarter of 2023 from Glocal Healthcare Private Limited (“Glocal”), which was deconsolidated as previously reported, compared to $3.6 million of revenue from Glocal for the second quarter of 2022.
  • Net loss attributable to UpHealth was $19.1 million, compared to a net loss attributable to UpHealth for the second quarter of 2022 of $12.4 million.

SK bioscience Presents Solution for Equitable Access of Vaccine at Regionalized Vaccine Manufacturing Collaborative of World Economic Forum

Retrieved on: 
Tuesday, May 23, 2023
Epidemic, Coalition for Epidemic Preparedness Innovations, Pan American Health Organization, SK, Multilateralism, WEF, Glocalization, Coalition, PAHO, CEPI, World Health Assembly, COVID-19, GAVI, African Center for Economic Transformation, Messenger, RVMC, Rochester Regional Health, Gavi, WHO, Vaccine, Ahn, World Health Organization, Pharmaceutical industry, Security (finance), Immunization, Health

Jaeyong Ahn, CEO of SK bioscience, presents the 'Glocalization' project to secure the global vaccine accessibility, claiming the importance of international cooperation to establish a regional-based vaccine hub at the Regionalized Vaccine Manufacturing Collaborative Side Event.

Key Points: 
  • Jaeyong Ahn, CEO of SK bioscience, presents the 'Glocalization' project to secure the global vaccine accessibility, claiming the importance of international cooperation to establish a regional-based vaccine hub at the Regionalized Vaccine Manufacturing Collaborative Side Event.
  • The RVMC is a global initiative launched at the World Economic Forum (WEF) in May 2022 to address inequality in vaccine distribution between few rich countries and low- and middle-income countries during the COVID-19 pandemic.
  • SK bioscience came up with a regional-based vaccine hub as a business model during the COVID-19 pandemic when inequality in COVID-19 vaccine distribution was exposed.
  • Currently, SK bioscience is preparing to establish the regional vaccine hubs in the Middle East, Africa, Southeast Asia, and Latin America.

Zoomlion Empowers Product and Market Development with Glocalization Strategy

Retrieved on: 
Monday, May 15, 2023
Marketing, Shenzhen Kaifa Technology Co., Ltd., Belt, Internet of things, Belt and Road Initiative, Information technology, New Era, Glocalization, Warehouse, Zoomlion

Zoomlion has accelerated its business model transformation in overseas markets converging a globalization mindset with localization, as well as empowering business operations through digitalization and optimizing strategic layout, to expand its international presence.

Key Points: 
  • Zoomlion has accelerated its business model transformation in overseas markets converging a globalization mindset with localization, as well as empowering business operations through digitalization and optimizing strategic layout, to expand its international presence.
  • The platform, known as the "port," supports the production lines, business units, and operations in terms of logistics and services for international operations.
  • The majority of the ground teams are local employees who can communicate better with the customers to provide efficient services and support.
  • Zoomlion's factory in Brazil has almost doubled its output this year, and the factory in India is now in construction.

UpHealth Announces First Quarter 2023 Financial Results

Retrieved on: 
Thursday, May 11, 2023
UPH, Employment, Pharmacy, International, RSU, Table, Integrated care, Telephone, PIPE, Prescription, Gaming Innovation Group, Sale, IGI, EBITDA, NYSE Listed Company Manual, Webcast, Growth, Adjustment, NYSE, Video game, Cryptocurrency, Glocalization

DELRAY BEACH, Fla., May 11, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. (“UpHealth” or the “Company”) (NYSE: UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced financial results for the first quarter ended March 31, 2023.

Key Points: 
  • Decreased 54% to $8.1 million
    Announced Strategic Sale of Innovations Group, Inc. for $56.0 million
    DELRAY BEACH, Fla., May 11, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. (“UpHealth” or the “Company”) (NYSE: UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced financial results for the first quarter ended March 31, 2023.
  • Gross margin expanded to 54% for the first quarter of 2023 from 39% for the first quarter of 2022.
  • Net loss attributable to UpHealth, Inc. for the first quarter of 2023 was $8.1 million, a 54% improvement compared to net loss attributable to UpHealth, Inc. for the first quarter of 2022 of $17.4 million.
  • Please refer to the discussion and tables under “Non-GAAP Financial Information.”
    On March 31, 2023, UpHealth reported $13.3 million of cash and cash equivalents.

UpHealth Announces Fourth Quarter 2022 Financial Results

Retrieved on: 
Thursday, March 2, 2023
NYSE, Veteran, EBITDA, GAAP, Audit committee, Annual general meeting, Asia Innovations Group, Shareholder, Integrated care, Prescription, Adjustment, IGI, TTC, Sale, UPH, Investment, Balance sheet, G&A, Growth, Service, Health, Operating cost, Mental health, Table, Video game, Film industry, Mobile phone, Pharmaceutical industry, Arms industry, Health care, Audit, Cryptocurrency, Management, Glocalization, Telehealth

DELRAY BEACH, Fla., March 02, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. (“UpHealth” or the “Company”) (NYSE: UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced financial results for the fourth quarter and year ended December 31, 2022.

Key Points: 
  • UpHealth Chief Executive Officer Sam Meckey said, “Our fourth quarter and full year results reflect solid growth and healthy margins.
  • 2023 is a foundational year for UpHealth, as we will ensure we have the necessary foundation for a technology and technology enabled-services business that can sustainably scale.”
    Fourth Quarter 2022 Financial Highlights:
    Revenues for the fourth quarter of 2022 increased 20% to $40.5 million compared to revenues for the fourth quarter of 2021 of $33.9 million and increased 32% compared to revenues of $30.7 million for the fourth quarter of 2021 after adjusting for the deconsolidation of Glocal.
  • Operating loss for the fourth quarter of 2022 was $13.4 million, a 96% improvement compared to operating loss in the fourth quarter of 2021 of $337.0 million.
  • Adjusted EBITDA for the fourth quarter of 2022 improved by $15.7 million, to $1.9 million, compared to Adjusted EBITDA for the fourth quarter of 2021 of $(13.8) million.

SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs

Retrieved on: 
Friday, January 27, 2023
SK, Health, Partnership, How to Prevent the Next Pandemic, COVID-19, Vaccine, Growth, Glocalization, Kingdom, History, KSA

During the presentation, Mr. Ahn shared the successful development history of the Korea's first COVID-19 vaccine while emphasizing the importance of global cooperation in terms of global health security.

Key Points: 
  • During the presentation, Mr. Ahn shared the successful development history of the Korea's first COVID-19 vaccine while emphasizing the importance of global cooperation in terms of global health security.
  • Further, he suggested a global cooperation based on the SK bioscience's vaccine R&D and manufacturing capabilities that can be transferred to the Middle East in the future.
  • Mr. Ahn said, "SK bioscience can transplant vaccine manufacturing facilities, technologies, and products to any countries in need based on the accumulated experiences in R&D and manufacturing we have been building.
  • SK bioscience is promoting the 'Glocalization' business based on its R&D and manufacturing capabilities.

UpHealth Announces Third Quarter 2022 Financial Results

Retrieved on: 
Thursday, December 29, 2022
International Court of Arbitration, Adjustment, Addiction, Partnership, Newsweek, ICA, Health, EBITDA, Annual general meeting, Compte rendu, GAAP, Audit committee, Securities and Exchange Board of India, Public Utility Holding Company Act of 1935, Security (finance), Form, International court, Kimberlite, NYSE, Exercise, Financial assistance (share purchase), Shareholder, UPH, CompTIA, Integrated care, Service, Bookkeeping, Management, Construction, Renewable energy, Video game, Risk management, Azim Premji, Glocalization

DELRAY BEACH, Fla., Dec. 29, 2022 (GLOBE NEWSWIRE) -- UpHealth, Inc. (“UpHealth” or the “Company”) (NYSE: UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced financial results for the third quarter ended September 30, 2022.

Key Points: 
  • Accordingly, the financial results of Glocal as of September 30, 2022, and for the three months then ended, are not included in the Company’s unaudited condensed consolidated financial statements.
  • We continue to pursue legal action both in India’s jurisdiction as well as before the International Court of Arbitration (the “ICA”) and will vigorously defend our interests and ownership of the Glocal asset.”
    Third Quarter 2022 Financial Highlights:
    Revenues for the third quarter of 2022 was $38.7 million, compared to revenues for the third quarter of 2021 of $45.2 million.
  • Revenues and gross margin by segment for the third quarter of 2022 were:
    Operating loss for the third quarter of 2022 was $120.0 million, a 2460% increase compared to operating loss in the third quarter of 2021 of $4.7 million.
  • Adjusted EBITDA for the third quarter of 2022 was $(1.2) million, compared to Adjusted EBITDA for the third quarter of 2021 of $3.1 million.

Modern Luxury Media Inks Digitally Driven Acquisition With Glocally to Accelerate Influencer Creator Network

Retrieved on: 
Tuesday, July 12, 2022
Technology, Marketing, Hamptons (magazine), Social media, Aspen Magazine, Acquisition, Solution, Ocean Drive, CEO, Instagram, Roc Nation, NEW, City, Twitter, Growth, TikTok, Partnership, Public relations, Retail, Glocalization, Facebook

NEW YORK, July 12, 2022 /PRNewswire/ -- Modern Luxury Media, the nation's largest luxury media company, today announces the acquisition of Glocally, a social content company that discovers and partners with the most engaging influencers and local content creators. 

Key Points: 
  • Glocally will join Modern Luxury Media as a new division to strengthen its commitment to the influencer creator economy across the luxury media company's roster of 85 brands from coast to coast.
  • "Modern Luxury and Glocally have obvious synergies that will create impactful and meaningful experiences for our clients.
  • Reaching an audience of more than 16 million, Modern Luxury is the nation's largest luxury media company and home to leading brands including Hampton's Magazine, Ocean Drive, and Aspen Magazine.
  • About MODERN LUXURY MEDIA: At Modern Luxury, connection and community define who we are.

Estée Lauder Launches Emerging Leaders Fund to Advance the Next Generation of Women Redefining Leadership

Retrieved on: 
Wednesday, May 4, 2022
Online Retail, Luxury, Professional Services, Philanthropy, Women, Fashion, Retail, Other Professional Services, Fund Raising, Foundation, Consumer, Vital Voices, YouTube, Lead, Twitter, 16 Days of Activism against Gender-based Violence, Woman, Fund, R. Torre & Company, Inc., Beauty, Partnership, Program, Perception, Vital, Leadership, LinkedIn, Female, Mark (given name), TikTok, Investor, Solution, CEO, Research, Man, Multimedia, Management, Cosmetics, Instagram, Glocalization, Facebook

Este Lauder, the flagship brand of The Este Lauder Companies Inc., is proud to announce the launch of the Este Lauder Emerging Leaders (ELEL) Fund, a charitable fund under The Este Lauder Companies Charitable Foundation.

Key Points: 
  • Este Lauder, the flagship brand of The Este Lauder Companies Inc., is proud to announce the launch of the Este Lauder Emerging Leaders (ELEL) Fund, a charitable fund under The Este Lauder Companies Charitable Foundation.
  • The ELEL Funds mission is to redefine leadership by supporting a new generation of emerging women leaders and challenging the gender stereotypes of leadership.
  • Through the work of the Este Lauder Emerging Leaders Fund and its program partners, we will champion women to contribute and lead in their workplaces and communities.
  • The Este Lauder Emerging Leaders Fund is a charitable fund of The Este Lauder Companies Charitable Foundation, a U.S. based charity incorporated and tax exempt in the United States of America.

Launch of Sunlight ElectroLiFe, Sunlight Group’s New Lightweight Lithium-ion Battery

Retrieved on: 
Monday, March 21, 2022
Technology, Mobile, Wireless, Sports, Automotive, Other Energy, Golf, Other Automotive, Energy, Networks, Glocalization, ESS, AGV (train), Group, Sunlight, Automation, Growth, Multimedia, EDT, CEO, Efficiency, Maintenance, Knowie, Electric battery

On Tuesday, March 29 at 10:00 AM (EDT), the company will present and demonstrate the ElectroLiFe battery at Sunlight booth #B7605.

Key Points: 
  • On Tuesday, March 29 at 10:00 AM (EDT), the company will present and demonstrate the ElectroLiFe battery at Sunlight booth #B7605.
  • It also has an extended lifespan of >2,000 cycles and can be connected to GLocal, Sunlight Groups cloud platform.
  • In attendance will be Lampros Bisalas, Sunlight Groups CEO, and Todd M. Sechrist, CEO and President of the subsidiary Sunlight Batteries USA.
  • This includes the new range of lithium-powered motive (Sunlight Li.ON FORCE), semi-traction (Sunlight ElectroLiFe) and reserve (Sunlight Li.ON ESS) batteries, as well Sunlight's cloud-based platform, GLocal, and smart Battery Monitoring System, KnoWi.